“UAE’s Health and Pharmaceutical Economic Growth & Innovative
Capacity” Dr.AminHussainAlAmiri.M.Sc,Ph.D.
Asst.UndersecretaryForPublicHealthPolicy&LicensingMinistryofHealth&PrevenAon,UAE
20171U.S-U.A.EBusinessCouncilHealthcare
Event
UAEHealthcareMarket:theStrengths….
UAEhasoneofthemostliberaltraderegimesintheGulfandaCractsstrongcapitalflowsfromacrosstheregion.
UAEisprogressivelydiversifyingitseconomy,whichhasreduceditsvulnerabilitytooilpricemovementscomparedwithotherGulfStates
OneofthemoredevelopedmarketsintheMiddleEast,withstronghealthcareinfrastructureandthehighestpercapitadrugexpenditureintheregion.
Strongpatenteddrugmarket,largelyasaresultofthecountry'spreferenceforthelatestmedicines.
LocalmanufacturingindustryacMvityhasincreasednotablyoverthepastfewyears,withastrongfocusonregionalandglobalexports.
IncreaseinpopulaMonnumbers,includingexpatriates,leadingtosignificantlyhigherhealthcareexpenditureandflourishingtrademarket.
2U.S-U.A.EBusinessCouncilHealthcareEvent
HealthcareInvestmentForecast2015-2025
3
ü UAE'shealthexpenditurereachedavalueof
AED56.26bn(USD15.32bn)in2015,equaAngtoUSD1,673percapita.
ü In2016,healthexpenditureincreasedby5%inlocalcurrencyterms,reachingAED59.15bn(USD16.12bn).
ü ItisforecastedtorisetoAED73.52bn(USD20.03bn)by2020,whichtranslatestoacompoundannualgrowthrate(CAGR)of5.5%.
ü Overtheextended2016-2025forecastperiod,healthexpenditureisexpectedtorisetoAED101.94bn(USD27.78bn),whichequatestoaCAGRof6.1%
ü Thegovernment'sshareoftotalhealthexpenditureisexpectedtofalloverourforecastperiodfrom71.3%in2015to60.7%by2025,aligningwiththestrategyofPPPandprivatesectorinvestmentencouragement.
UnitedArabEmiratesPharmaceu3cals&HealthcareReportQ1-2017BMI:BusinessMonitorInterna3onal
U.S-U.A.EBusinessCouncilHealthcareEvent
Facts&Figures:HealthcareProvidersinUAE
U.S-U.A.EBusinessCouncilHealthcareEvent 4
ThereissMllaneedformorePhysicians,nursesandpharmacists;evenwiththecurrentincreaseitisnotkeepingpacewithshiWsinHealthImprovement
StrategyforUAE.
Source:BMIEspicom
PharmaceuMcalMarket:TheUpdates
5
ü In2015,theUAEpharmaceuAcalmarketreached
avalueofAED8.84bn(USD2.41bn),represenAng15.6%ofhealthcareexpenditure.
ü In2016themarketreachedavalueofAED9.61bn(USD2.62bn).
ü By2020,itiscalculatedthatdrugexpenditurewillreachavalueofAED13.13bn(USD3.58bn),equaAngtoacompoundannualgrowthrate(CAGR)of8.2%
ü by2025,drugexpenditurewillbeworth
AED21.74bn(USD5.92bn)drivenbypopulaAongrowth,achangingdiseaseprofile,andtheuseofmodernmedicinessuchasbiotechnologydrugs.
ü By2025thepharmaceuAcalmarketwillmakeup0.85%oftheUAE'sGDP,upfrom0.70%in2015.
UnitedArabEmiratesPharmaceu3cals&HealthcareReportQ12017-BMI:BusinessMonitorInterna3onal
UnitedArabEmiratesPharmaceu3cals&HealthcareReportQ12017-BMI:BusinessMonitorInterna3onal
U.S-U.A.EBusinessCouncilHealthcareEvent
PharmaceuMcalTradeforecast2011-2020
6
v PharmaceuAcalimportsandexportsstoodatAED8.78bn(USD2.39bn)andAED3.37bn(USD917mn)respecAvelyin2015.
v ImportswillincreasetoAED14.14bn(USD3.85bn)byend2016andAED17.30bn(USD4.74bn)by2020,atacompoundannualgrowthrate(CAGR)of5.1%
v ExportsexpectedtorisetoAED3.49bn(USD950mn)byend2016andAED4.14bn(USD1.13bn)by2020-CAGRof4.2%.Ø UAEimportspharmaceuAcalproductsfrommainly72countries,10countriesaccountforapproximately
80%oftheenAresupply.Ø ThesecountriesarepredominatelyWesternnaAons(namelytheUK,Switzerland,Germany,Belgium,
France,Spain,ItalyUSAandAustralia)withthedrugscomprisinghigh-valuepatentedproductsUnitedArabEmiratesPharmaceu3cals&HealthcareReportQ12017-
BMI:BusinessMonitorInterna3onal
U.S-U.A.EBusinessCouncilHealthcareEvent
MOHAP:RegulatoryConAnuumLegislaAons&PoliciesDevelopment
MOHAPtogetherwithconcernedstakeholdersdevelopedanumberoflegislaMons(FederalLawsandDecrees).Someexamplesinclude:• PrivateMedicalHealthFaciliMesFederal
LawNo.(4)fortheyear2015• MedicalLiabilityFederalLaw(byDecree)
No.(4)fortheYear2016• OrganTransplantRegulaMonFederalLaw
No.(5)fortheyear2016• CommunicablediseaseControlFederalLaw
No.(14)fortheyear2014anditsExecuMveDecreeNo.(6)fortheyear2016
• NaMonalStrategicStockpileDecreeNo.(872)fortheyear2016anditsCabinetExecuMvedecree
7
TrendAnalysis–HealthLegislaAons
MOHAPWebsite
U.S-U.A.EBusinessCouncilHealthcareEvent
MOHAP:RegulatoryConMnuum(cont.)• EnhancingregulatorypracAcestoensureaccessibilityofacomprehensivequality
healthservicestoallpopulaAonareatthetopofUAEgovernmentagenda
• Licensing&Monitoring
the3Ps:
• TheregulaAonofpharmaceuAcalsandmedicaltechnologies/devicesinUAEisaimedto:
Synopsis of Regulations and Licensing Continuum in UAE
8
Ensuringproductsafety,qualityand
effecAveness ProvidingthepublicwithAmelyaccesstogenuinesafeproducts
Premises PracAces Products
U.S-U.A.EBusinessCouncilHealthcareEvent
Professional’QualificaAonRequirements(PQR)
AunifiedguidelinewasdevelopedbytheMinistryofHealthandPrevenMon,HealthAuthority–AbuDhabi(HAAD),andDubaiHealthAuthority(DHA).
ThedocumentsetstheprofessionalqualificaMonrequirementsnecessarytolicensehealthcareprofessionalsintheUAEandtransferoflicenserequirementsacrosstheEmirates.
AlignedwithinternaMonalstandards,thedocumentalsoidenMfiestheminimumacceptablequalificaMonsandexperiencesforeligibilityforlicensuretopracMcemedicalprofession.
9U.S-U.A.EBusinessCouncilHealthcareEvent
NaAonalUnifiedHospitalStandards
HealthRegulatoryAuthoriMesintheUnitedArabEmirates(UAE)representedby:MOHAP,HAADandDHA,developedtheNaMonalUnifiedHospitalStandards-amilestonetowardsfulfillingtheUAEstrategicobjecMvestoimprovethehealthcareserviceprovisionacrossthecountry.
ThisdocumentprovidesabasefortheConcernedAuthoriMestoassesstheperformanceofhospitalstoensuresafeandcompetentdeliveryofservices.
Scope:ThisregulaMonisapplicabletoallhospitalestablishmentsintheUAEthataresubjecttolicensure.Allcategoriesofhospitals,inclusiveofgeneralandspecialtyincludingallgovernmental,semi-governmentalandprivatealongwithhospitalsoperaMnginfreezoneareasexcludingDubaiHealthcareCityAuthorityshallcomplywiththisregulaMon
10U.S-U.A.EBusinessCouncilHealthcareEvent
ProgressofPharmaceuAcalIndustryinUAE
PharmaceuAcalFactories InternaAonalScienAficOffices
11U.S-U.A.EBusinessCouncilHealthcareEvent
12
• UAE is the only country in theMENA region that adopted an effecMve fast track system forregistraMon of innovator drugs: Fast Track Innovator, which allowed quick access ofinnovatordrugstoUAEpaMents&paMentsfromneighboringcountrieswhoseektreatmentintheUAE.
AccessibilitytoNewTherapies
Harvoni HepaMMsC August2015 Fourth
Tagrisso LungCancer May2016 First
Gardasil HPVVaccine May2016 Second
Synjardy Type2Diabetes May2016 SecondU.S-U.A.EBusinessCouncilHealthcare
Event
13U.S-U.A.EBusinessCouncilHealthcareEvent
National Agenda Vision Focus on:
6)CohesiveSocietyandPreservedIdenAty
1)SafePublicandFairJudiciary
3)CompeAAveKnowledgeEconomy
2)First-RateEducaAonSystem
4)World-ClassHealthcare
5)SustainableEnvironmentandInfrastructure
14U.S-U.A.EBusinessCouncilHealthcareEvent
15
With our Citizens at the heart of development, we strive to become one of
the most competitive countries in the world”
U.S-U.A.EBusinessCouncilHealthcareEvent